Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q4 CY2024, with sales up 4.2% ...

Key Takeaways The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Read here for an analysis of Walgreens Boots Alliance's performance and key issues, including declining stock value and ...

CVS Health reports strong fourth-quarter earnings, with revenue beating estimates despite rising insurance costs. Shares rise ...

ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare.